Human Pathology
Volume 37, Issue 1 , Pages 78-86 , January 2006

Expression and localization of inhibitor of apoptosis proteins in normal human tissues

  • Barbara Vischioni, MD

      Affiliations

    • Department of Medical Oncology, VU University Medical Center, HV1081 Amsterdam, The Netherlands
    • ,
  • Paul van der Valk, MD, PhD

      Affiliations

    • Department of Pathology, VU University Medical Center, HV1081 Amsterdam, The Netherlands
    • ,
  • Simone W. Span, Ing

      Affiliations

    • Department of Medical Oncology, VU University Medical Center, HV1081 Amsterdam, The Netherlands
    • ,
  • Frank A.E. Kruyt, PhD

      Affiliations

    • Department of Medical Oncology, VU University Medical Center, HV1081 Amsterdam, The Netherlands
    • ,
  • Jose A. Rodriguez, PhD

      Affiliations

    • Department of Medical Oncology, VU University Medical Center, HV1081 Amsterdam, The Netherlands
    • ,
  • Giuseppe Giaccone, MD, PhD

      Affiliations

    • Department of Medical Oncology, VU University Medical Center, HV1081 Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Division of Medical Oncology, Academic Hospital Vrije Universiteit, HV1081 Amsterdam, The Netherlands.

Received 18 May 2005 ,Revised 22 September 2005 ,Accepted 23 September 2005.

References 

  1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257
  2. Gupta S. A decision between life and death during TNF-alpha–induced signaling. J Clin Immunol. 2002;22:185–194
  3. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456–1462
  4. Cryns V, Yuan J. Proteases to die for. Genes Dev. 1998;12:1551–1570
  5. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1–16
  6. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998;17:2215–2223
  7. Duckett CS, Nava VE, Gedrich RW, et al. A conserved family of cellular genes related to the baculovirus IAP gene and encoding apoptosis inhibitors. EMBO J. 1996;15:2685–2694
  8. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol. 2002;3:401–410
  9. LaCasse EC, Baird S, Korneluk RG, et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998;17:3247–3259
  10. Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 2000;6:1796–1803
  11. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917–921
  12. Liston P, Roy N, Tamai K, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996;379:349–353
  13. Gupta S. A role of inhibitor of apoptosis (IAP) proteins in increased lymphocyte apoptosis in aged humans. Mech Ageing Dev. 2004;125:99–101
  14. Nachmias B, Ashhab Y, Ben Yehuda D. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol. 2004;14:231–243
  15. Li J, Kim JM, Liston P, et al. Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia. Endocrinology. 1998;139:1321–1328
  16. Wang CY, Mayo MW, Korneluk RG, et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998;281:1680–1683
  17. Stehlik C, de Martin R, Kumabashiri I, et al. Nuclear factor (NF)–kappaB–regulated X-chromosome–linked iap gene expression protects endothelial cells from tumor necrosis factor alpha–induced apoptosis. J Exp Med. 1998;188:211–216
  18. Yang Y, Fang S, Jensen JP, et al. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 2000;288:874–877
  19. Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c–dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102:33–42
  20. Suzuki Y, Imai Y, Nakayama H, et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell. 2001;8:613–621
  21. Young SS, Liston P, Xuan JY, et al. Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2. Mamm Genome. 1999;10:44–48
  22. Ka H, Hunt JS. Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol. 2003;163:413–422
  23. Ponnelle T, Chapusot C, Martin L, et al. Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis. Pathol Res Pract. 2003;199:723–731
  24. Ferreira CG, van der Valk P, Span SW, et al. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non–small-cell lung cancer patients. Ann Oncol. 2001;12:799–805
  25. Imoto I, Tsuda H, Hirasawa A, et al. Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res. 2002;62:4860–4866
  26. Dai Z, Zhu WG, Morrison CD, et al. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Hum Mol Genet. 2003;12:791–801
  27. Gordon GJ, Appasani K, Parcells JP, et al. Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis. 2002;23:1017–1024
  28. Liu SS, Tsang BK, Cheung ANY, et al. Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer. 2001;37:1104–1110
  29. Li J, Feng Q, Kim JM, et al. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology. 2001;142:370–380
  30. Krajewska M, Krajewski S, Banares S, et al. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res. 2003;9:4914–4925
  31. Krajewska M, Kim H, Kim C, et al. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Clin Cancer Res. 2005;11:5451–5461
  32. Shiraki K, Sugimoto K, Yamanaka Y, et al. Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma. Int J Mol Med. 2003;12:705–708
  33. Imoto I, Yang ZQ, Pimkhaokham A, et al. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res. 2001;61:6629–6634
  34. Hasegawa T, Suzuki K, Sakamoto C, et al. Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia. Blood. 2003;101:1164–1171
  35. Yang L, Cao Z, Yan H, et al. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 2003;63:6815–6824
  36. Vischioni B, Giaccone G, Span SW, et al. Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2. Exp Cell Res. 2004;298:535–548
  37. Plenchette S, Cathelin S, Rebe C, et al. Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated event. Blood. 2004;104:2035–2043
  38. Liston P, Fong WG, Kelly NL, et al. Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol. 2001;3:128–133
  39. Verhagen AM, Coulson EJ, Vaux DL. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol. 2001;2:3009;[Reviews]
  40. Schimmer AD, Welsh K, Pinilla C, et al. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell. 2004;5:25–35

☆ B. Vischioni was supported by the ESMO Foundation (Lugano, Switzerland), and J.A. Rodriguez was supported by the Walter Bruckerhoff Stiftung (Zurich, Switzerland).

PII: S0046-8177(05)00532-0

doi: 10.1016/j.humpath.2005.09.022

Human Pathology
Volume 37, Issue 1 , Pages 78-86 , January 2006

Article Tools

* Image Usage & Resolution